Atara Biotherapeutics (ATRA) Q1 2026 Earnings

16MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.98
-0.15
1.67
3.5

Details

Expected EPS
-0.1759
Actual EPS
-0.25
Surprise EPS
-0.07
Surprise Percent
+42.13%

Description

Atara Biotherapeutics (ATRA) has reported earnings of -0.25 per share for Q1 2026.

0 Comments

Share your thoughts